topotecan has been researched along with arq 197 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belani, C; Cristea, MC; Gandara, DR; Gitlitz, BJ; Goldkorn, A; Gong, IY; Groshen, SG; Kelly, K; Koczywas, M; Liu, SV; Newman, EM; Reckamp, KL; Semrad, TJ; Synold, TW; Xu, T; Xu, Y | 1 |
1 trial(s) available for topotecan and arq 197
Article | Year |
---|---|
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Monitoring; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Neutropenia; Proto-Oncogene Proteins c-met; Pyrrolidinones; Quinolines; Thrombocytopenia; Topotecan; Treatment Failure; Treatment Outcome | 2018 |